33rd Annual Meeting 2019

Registration has now closed!

The 33rd Annual Meeting Sponsored by Gentronix will be held from the 19th – 20th June 2019 at Deansgate Hilton, Manchester.

The meeting will start on the evening of the 19th with a keynote from David Kirkland on “Regulatory Assessment of Genotoxicity Data: Past, Present and Future” followed by a drinks reception, sponsored by Instem and Litron Laboratories, and bowl food, an excellent opportunity for networking and catching up with colleagues.

The 20th will have half a day on “Regulatory Genetic Toxicology: Theory” covering new challenges including oligos and medical devices, while the afternoon will be interactive workshops on proof of exposure and when negative is equivocal.

Download the Meeting Flyer for more information and see the full Agenda below.

There are travel bursaries available as well as reduced rates for members of EEMGS and affiliated societies.

Accommodation is available at the Hilton at £175 for one night with breakfast using the code AIGG19 on the Hilton website, or alternatively by contacting the reservation manager Jack Naylor (0161 870 1641 or Jack.naylor@hilton.com) to make a booking directly by the end of the 31st of May.

For ideas for alternative hotels see the map below.

Follow us on Twitter
Follow us on LinkedIn


Hilton Deansgate (Conference Venue)
Premier Inn Manchester City Centre Piccadilly
Premier Inn Manchester City Centre Portland Street
Holiday Inn Manchester City Centre
Holiday Inn Express
Premier Inn Manchester Deansgate Locks
Mercure Manchester Piccadilly


Wednesday 19th June Evening Session

18:00-19:00 Registration and Welcome with Canapes
19:00-20:00 Regulatory Assessment of Genotoxicity Data: Past, Present and Future David Kirkland Kirkland Consulting
20:00-23:00 Networking with drinks and bowl food

Thursday 20th June Morning Session

09:30-10:00 Coffee, Registration and Welcome
10:00-10:30 Genetox testing of medical devices – how different can it be? Phil Clay  Chorley Consulting
10:30-11:00 How low can you go? An analysis of lowest effective dose in the Ames test. Paul Rawlinson Gentronix
11:00-11:30 Should the full gene tox battery be needed for antisense oligos? Ann Doherty AstraZeneca
11:30-12:00 Deriving compound-specific acceptable daily intakes/Permissible Daily Exposures for impurities in pharmaceuticals Liz Martin AstraZeneca
12:00-12:15 Annual General Meeting
12:15-13:30 Lunch

Thursday 20th June Afternoon Session

13:30-14:20 Genotoxicity assessment of an agrochemical by conservative EU member states and EFSA Eva Lessmann and Paul Rawlinson Syngenta and Gentronix
Regulatory approaches to using HCD for interpretation of genotoxicity studies Carol Beevers Exponent
14:45-15:00 Coffee Break
15:00-15:25 MLA data: contradictory data and the trouble with regulators  Damian Bowen  ERM
15:25-15:50 Case study with ethopropos Paul Fowler  FSTox Consulting
15:50-16:00 Wrap-up
16:00 Close of Meeting